A Belgian company creating virtual reality systems for sedation in surgery and invasive procedures is raising €10 million in its first venture funding round. . . . → Read More: Digital Sedation Company Raises $11.8M in Early Funds
|
|||||
|
       
  |
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines. . . . → Read More: Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines 
Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism. . . . → Read More: Small Antibody Shown to Block Covid-19 Infection 
An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain. . . . → Read More: Brain Signal Synchronization Device in Development 
Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S. . . . → Read More: Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial  Comments are closed  Joint ventures/collaborations, New products  biomedical, biotechnology, clinical trials, Covid-19, Europe, life sciences, pharmaceuticals, U.K. 
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion. . . . → Read More: Food Allergy Biotech Acquired for $2.6B One comment - (Comments are closed) Finance biomedical, biotechnology, equity, Europe, FDA, investment, life sciences, merger, pharmaceuticals 
Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells. . . . → Read More: Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy Comments are closed Joint ventures/collaborations, New products Asia, biomedical, biotechnology, China, Covid-19, Europe, life sciences, pharmaceuticals, university 
A developer of small-molecule therapies for autoimmune diseases, including multiple sclerosis, and other immune disorders is being acquired by Sanofi. . . . → Read More: Sanofi Acquires Immune Disease Biotech in $3.7B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, clinical trials, equity, Europe, investment, licensing, life sciences, merger, pharmaceuticals 
A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospitalized with pneumonia from Covid-19 infections. . . . → Read More: Trial Testing Rare Disease Drug for Covid-19 Pneumonia Comments are closed New products biomedical, biotechnology, clinical trials, Covid-19, Europe, life sciences, pharmaceuticals 
Physical symptoms experienced by people with Covid-19 infections are well documented over the past few months, but the psychological toll is also beginning to get attention. . . . → Read More: Infographic – Mental Health Effects of Pandemic One comment - (Comments are closed) Business conditions Australia, behavioral science, biomedical, Covid-19, Europe, health care, psychiatric, statistics |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||